Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Nov 1;180(5):1889-900.
doi: 10.1084/jem.180.5.1889.

Humoral immune responses in CD40 ligand-deficient mice

Affiliations

Humoral immune responses in CD40 ligand-deficient mice

B R Renshaw et al. J Exp Med. .

Abstract

Individuals with X-linked hyper-IgM syndrome fail to express functional CD40 ligand (CD40L) and, as a consequence, are incapable of mounting protective antibody responses to opportunistic bacterial infections. To address the role of CD40L in humoral immunity, we created, through homologous recombination, mice deficient in CD40L expression. These mice exhibited no gross developmental deficiencies or health abnormalities and contained normal percentages of B and T cell subpopulations. CD40L-deficient mice did display selective deficiencies in humoral immunity; basal serum isotype levels were significantly lower than observed in normal mice, and IgE was undetectable. Furthermore, the CD40L-deficient mice failed to mount secondary antigen-specific responses to immunization with a thymus-dependent antigen, trinitrophenol-conjugated keyhole limpet hemocyanin (TNP-KLH). By contrast, the CD40L-deficient mice produced antigen-specific antibody of all isotypes except IgE in response to the thymus-independent antigen, DNP-Ficoll. These results underscore the requirement of CD40L for T cell-dependent antibody responses. Moreover, Ig class switching to isotypes other than IgE can occur in vivo in the absence of CD40L, supporting the notion that alternative B cell signaling pathways regulate responses to thymus-independent antigens.

PubMed Disclaimer

References

    1. J Immunol. 1994 May 1;152(9):4262-9 - PubMed
    1. J Immunol. 1994 Mar 1;152(5):2190-7 - PubMed
    1. J Immunol. 1978 Aug;121(2):566-72 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1612-6 - PubMed
    1. J Exp Med. 1981 Jan 1;153(1):1-12 - PubMed

MeSH terms